CRIS Current Research Information System

CAPELLARI, SABINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.305
AS - Asia 12.497
EU - Europa 10.567
SA - Sud America 813
Continente sconosciuto - Info sul continente non disponibili 729
AF - Africa 656
OC - Oceania 33
Totale 40.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.002
SG - Singapore 3.400
VN - Vietnam 3.147
CN - Cina 2.993
IT - Italia 2.477
GB - Regno Unito 2.313
DE - Germania 1.627
HK - Hong Kong 950
SE - Svezia 746
NL - Olanda 714
FR - Francia 609
BR - Brasile 590
IN - India 552
RU - Federazione Russa 459
UA - Ucraina 386
IE - Irlanda 341
BD - Bangladesh 315
KR - Corea 294
FI - Finlandia 215
JP - Giappone 207
CI - Costa d'Avorio 177
ZA - Sudafrica 171
CA - Canada 164
SC - Seychelles 144
EE - Estonia 132
AT - Austria 103
ID - Indonesia 97
JO - Giordania 90
PH - Filippine 83
TG - Togo 81
AR - Argentina 79
MX - Messico 71
BG - Bulgaria 67
CH - Svizzera 58
TH - Thailandia 54
ES - Italia 53
BE - Belgio 52
IQ - Iraq 49
PL - Polonia 45
TR - Turchia 40
UZ - Uzbekistan 34
CO - Colombia 32
TW - Taiwan 32
EC - Ecuador 31
AU - Australia 29
GR - Grecia 29
SA - Arabia Saudita 26
DK - Danimarca 24
VE - Venezuela 21
PK - Pakistan 19
LT - Lituania 17
MY - Malesia 16
PY - Paraguay 16
RO - Romania 16
PE - Perù 15
CL - Cile 14
HR - Croazia 14
IR - Iran 14
JM - Giamaica 14
NG - Nigeria 14
MA - Marocco 13
CZ - Repubblica Ceca 12
TN - Tunisia 12
IL - Israele 11
LB - Libano 11
AE - Emirati Arabi Uniti 10
CR - Costa Rica 9
MD - Moldavia 9
GT - Guatemala 8
HU - Ungheria 8
EG - Egitto 7
NO - Norvegia 7
UY - Uruguay 7
HN - Honduras 6
KE - Kenya 6
NI - Nicaragua 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
AL - Albania 5
DZ - Algeria 5
OM - Oman 5
PS - Palestinian Territory 5
SN - Senegal 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
KZ - Kazakistan 4
LV - Lettonia 4
PR - Porto Rico 4
SR - Suriname 4
AO - Angola 3
KH - Cambogia 3
LY - Libia 3
MC - Monaco 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 39.815
Salva come PNG Salva come JPEG
Città #
Singapore 2.364
Southend 1.983
Ashburn 1.549
Fairfield 1.187
Houston 1.013
Chandler 935
Hong Kong 889
San Jose 720
Dong Ket 630
Ho Chi Minh City 602
Hefei 600
Ann Arbor 594
Woodbridge 589
Seattle 580
Wilmington 528
Bologna 527
Hanoi 513
Cambridge 452
Frankfurt am Main 423
Princeton 409
Council Bluffs 398
Santa Clara 391
Beijing 368
Dublin 341
Eygelshoven 338
Boardman 326
Dallas 302
Seoul 254
Los Angeles 245
Lauterbourg 237
Jacksonville 230
New York 197
Tokyo 184
Abidjan 177
Nanjing 166
Westminster 163
Helsinki 151
Redmond 148
Milan 147
Turin 139
Berlin 128
Padova 127
Buffalo 122
Munich 122
Florence 97
Redondo Beach 96
Da Nang 90
Amman 89
Lomé 81
São Paulo 81
Jinan 80
Shenyang 79
Haiphong 75
San Diego 75
Saint Petersburg 74
Bengaluru 69
Rome 69
Sofia 64
Shanghai 63
Vienna 63
Chicago 61
Guangzhou 61
Changsha 60
Tianjin 58
London 57
Hebei 55
Medford 54
Nuremberg 54
Des Moines 52
Nanchang 52
Jakarta 51
Brussels 50
Lappeenranta 49
Phoenix 49
Montreal 48
Mülheim 44
San Francisco 41
Olalla 39
Toronto 39
Amsterdam 37
Verona 37
Boydton 32
Orem 32
Yubileyny 32
Zhengzhou 32
Can Tho 30
Falls Church 30
Jiaxing 30
Warsaw 30
Atlanta 28
Dearborn 28
Imola 28
Mexico City 28
Hangzhou 27
Hải Dương 27
Naples 26
Redwood City 26
Bern 25
Haikou 25
Chennai 24
Totale 25.321
Salva come PNG Salva come JPEG
Nome #
A new potential biomarker for dementia with Lewy bodies 913
Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding 578
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. 523
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 373
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 362
Skin biopsy and microneurography disclose selective noradrenergic dysfunction due to dopamine-β-hydroxylase deficiency 317
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 310
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project 305
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 301
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 297
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 285
Messenger RNA processing is altered in autosomal dominant leukodystrophy 281
Cognitive rehabilitation and transcranial direct current stimulation in a patient with posterior cortical atrophy: An fMRI study 267
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 265
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 260
Mice overexpressing lamin B1 in oligodendrocytes recapitulate the age-dependent motor signs, but not the early autonomic cardiovascular dysfunction of autosomal-dominant leukodystrophy (ADLD) 255
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 247
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 245
A case of fatal familial insomnia in Africa. 244
Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian population 240
Abnormal in vivo cerebral energy metabolism in Huntington’s disease: preliminary findings 237
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study 237
Binary transformation of sequencing data to explore functional genetic patterns. 233
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 231
Benign tremulous parkinsonism in a patient with dardarin mutation. 231
Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions 230
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 229
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 228
Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy 223
The RET51/FKBP52 complex and its involvement in Parkinson disease. 222
Color choice preference in cognitively impaired patients: A look inside alzheimer’s disease through the use of lüscher color diagnostic 222
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? 218
Human figure drawing distinguishes Alzheimer’s patients: a cognitive screening test study 217
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 212
Behçet disease presenting with movement disorders and antibasal ganglia antibodies 212
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 212
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation 212
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients 212
A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. 211
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 210
Age at onset in genetic prion disease and the design of preventive clinical trials 210
A new national survey of centers for cognitive disorders and dementias in Italy 209
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by theCYP4X1gene 208
Alterazione del metabolismo energetico cerebrale in vivo nella malattia di Huntington: dati preliminari 206
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 204
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants 201
Lack of association between five serotonin metabolism-related genes and medication overuse headache 200
"Agrypnia excitata'' in a case of sporadic Creutzfeldt-Jakob disease VV2 200
Discrepancies in reporting the CAG repeat lengths for Huntington's disease. 200
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study 200
Arylsulphatase A activity in familial parkinsonism: a pathogenetic role? 199
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 197
Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: A single-center study 196
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 196
Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer’s Disease 194
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene. 193
Quantifying prion disease penetrance using large population control cohorts 193
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance 193
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease 192
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 189
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. 188
Multimodal investigation of melanopsin retinal ganglion cells in Alzheimer's disease 187
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. 187
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 186
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 185
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 185
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 182
Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients 182
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 179
Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study 178
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 178
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 177
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 177
Observing movement disorders: best practice proposal in the use of video recording in clinical practice 177
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. 176
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 176
Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions 175
Distribution of Diffusivity Changes in Subcortical Deep Gray Matter in Prion Diseases 175
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 175
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 173
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 173
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 173
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. 172
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients 169
PROTEIN AMYLOIDOSIS ASSOCIATED WITH A NOVEL STOP CODON MUTATION IN PRNP 168
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 168
Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN‐RND) 167
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 167
Neurosyphilis orofacial dyskinesia: the candy sign. 167
The Degree of Cardiovascular Autonomic Dysfunction is not Different in GBA-Related and Idiopathic Parkinson's Disease Patients: A Case-Control Instrumental Evaluation 166
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia 166
Clinical and genetic characteristics of late-onset Huntington's disease 166
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 166
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification 165
Heterogeneity of truncated fragments distinct from PrP27-30 correlates with clinico-pathological subtypes of Creutzfeldt-Jakob disease 165
History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease 165
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. 165
Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period: A cohort study 164
Fragile X premutation tremor/ataxia syndrome (FXTAS): a case with characteristic clinical and MR features. 164
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 164
Totale 22.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.621 0 138 246 212 350 187 87 418 186 382 797 618
2022/20234.230 444 549 192 544 313 298 155 279 708 110 403 235
2023/20241.268 84 182 107 137 109 172 79 110 43 107 75 63
2024/20255.185 239 750 411 362 671 280 468 186 158 452 225 983
2025/202614.203 969 1.328 1.329 1.050 1.451 1.059 1.806 450 2.398 1.073 746 544
2026/20271.224 668 556 0 0 0 0 0 0 0 0 0 0
Totale 40.600